[ad_1]
Seattle, June 28, 2021 (GLOBE NEWSWIRE) – According to data from Coherent Market Insights, the value of the global thrombectomy device market is estimated to be US$ 137.16 billion 2020 year And is expected to be exhibited 7.2% compound annual growth rate During the forecast period (2020-2027).
Main trends and analysis Worldwide Thrombectomy equipment market:
The major players operating in the market are focusing on the product development, launch and approval of advanced thrombectomy devices with novel features, which are expected to drive market growth during the forecast period.
For example, in June 2018, MicroVention, Inc., a US subsidiary of Terumo Corporation, announced that the US FDA (Food and Drug Administration) approved its new indication SOFIA catheter (soft torque catheter for intracranial access). This The new approval will allow the product to be used in contact suction procedures for the treatment of acute ischemic stroke.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/2254
In addition, major players operating in the global thrombectomy device market are focusing on adopting inorganic growth strategies, such as partnerships and acquisitions, to increase their market share in the global market.
For example, in November 2018, Boston Scientific announced plans to acquire the UK-based company BTG plc. The company is a developer and marketer of minimally invasive surgery products for cancer and vascular diseases, as well as acute care drugs.
Main market points:
Due to the increasing incidence of stroke and thrombosis, as well as the technological advancement of thrombectomy devices, the global thrombectomy device market is expected to grow at a compound annual growth rate of 7.2% during the forecast period. For example, in October 2020, CERENOVUS,…
The full story on Benzinga.com
[ad_2]
Source link
